SmarTrend identified a Downtrend for Celgene Corp (NASDAQ:CELG) on October 13th, 2017 at $137.01. In approximately 6 months, Celgene Corp has returned 34.56% as of today's recent price of $89.65. Over the past year, Celgene Corp …
When Celgene (NASDAQ: CELG) makes a mistake, it's a doozy. The big biotech reported on Tuesday that it had received a Refusal to File letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for …
As a result of these false statements and/or omissions, the price of Celgene stock was artificially inflated during the …
A number of biotech firms that have real long-term growth have for some reason, cheaper share prices than you’d expect, and Celgene Corporation (NASDAQ:CELG) could be one of the biggest bargains of all. After reporting less than …
On Thursday before the open, Celgene Corporation (NASDAQ:CELG) reported its fourth-quarter earnings results. The company beat on earnings per share and revenue expectations. It also provided good, but not great guidance (more on …
When investors are looking for high growth and reasonable valuations in the biotech space, Celgene Corporation (NASDAQ:CELG) is one of the first companies to come to mind. However, October was not kind to the CELG stock …